Luckys Pharma Lab Private Limited

Luckys Pharma Lab Pvt. Ltd is a premium pharmaceutical company based in Indore (MP). Being  a renowned supplier of high-quality healthcare, offering PCD pharma franchise possibilities in a number of therapeutic areas, including gynecology, respiratory, cardiac, and general. Our extensive product line satisfies the ever evolving demands of the healthcare sector. Franchisee partner receive comprehensive support, such as product upgrades, marketing assistance, and promotional materials. Come along with us as we significantly improve healthcare. Investigate our franchise opportunities to join us in promoting health and wellbeing.

Luckys Pharma Lab Pvt. Ltd is a premium pharmaceutical company based in Indore (MP). Being  a renowned supplier of high-quality healthcare, offering PCD pharma franchise possibilities in a number of therapeutic areas, including gynecology, respiratory, cardiac, and general. Our extensive product line satisfies the ever evolving demands of the healthcare sector. Franchisee partner receive comprehensive support, such as product upgrades, marketing assistance, and promotional materials. Come along with us as we significantly improve healthcare. Investigate our franchise opportunities to join us in promoting health and wellbeing.

Luckys Pharma Lab Pvt. Ltd is a premium pharmaceutical company based in Indore (MP). Being  a renowned supplier of high-quality healthcare, offering PCD pharma franchise possibilities in a number of therapeutic areas, including gynecology, respiratory, cardiac, and general. Our extensive product line satisfies the ever evolving demands of the healthcare sector. Franchisee partner receive comprehensive support, such as product upgrades, marketing assistance, and promotional materials. Come along with us as we significantly improve healthcare. Investigate our franchise opportunities to join us in promoting health and wellbeing.

Luckys Pharma Lab Pvt. Ltd is a premium pharmaceutical company based in Indore (MP). Being  a renowned supplier of high-quality healthcare, offering PCD pharma franchise possibilities in a number of therapeutic areas, including gynecology, respiratory, cardiac, and general. Our extensive product line satisfies the ever evolving demands of the healthcare sector. Franchisee partner receive comprehensive support, such as product upgrades, marketing assistance, and promotional materials. Come along with us as we significantly improve healthcare. Investigate our franchise opportunities to join us in promoting health and wellbeing.

Luckys Pharma Lab Pvt. Ltd is a premium pharmaceutical company based in Indore (MP). Being  a renowned supplier of high-quality healthcare, offering PCD pharma franchise possibilities in a number of therapeutic areas, including gynecology, respiratory, cardiac, and general. Our extensive product line satisfies the ever evolving demands of the healthcare sector. Franchisee partner receive comprehensive support, such as product upgrades, marketing assistance, and promotional materials. Come along with us as we significantly improve healthcare. Investigate our franchise opportunities to join us in promoting health and wellbeing.

Luckys Pharma Lab Pvt. Ltd is a premium pharmaceutical company based in Indore (MP). Being  a renowned supplier of high-quality healthcare, offering PCD pharma franchise possibilities in a number of therapeutic areas, including gynecology, respiratory, cardiac, and general. Our extensive product line satisfies the ever evolving demands of the healthcare sector. Franchisee partner receive comprehensive support, such as product upgrades, marketing assistance, and promotional materials. Come along with us as we significantly improve healthcare. Investigate our franchise opportunities to join us in promoting health and wellbeing.

Luckys Pharma Lab Pvt. Ltd is a premium pharmaceutical company based in Indore (MP). Being  a renowned supplier of high-quality healthcare, offering PCD pharma franchise possibilities in a number of therapeutic areas, including gynecology, respiratory, cardiac, and general. Our extensive product line satisfies the ever evolving demands of the healthcare sector. Franchisee partner receive comprehensive support, such as product upgrades, marketing assistance, and promotional materials. Come along with us as we significantly improve healthcare. Investigate our franchise opportunities to join us in promoting health and wellbeing.

Luckys Pharma Lab Pvt. Ltd is a premium pharmaceutical company based in Indore (MP). Being  a renowned supplier of high-quality healthcare, offering PCD pharma franchise possibilities in a number of therapeutic areas, including gynecology, respiratory, cardiac, and general. Our extensive product line satisfies the ever evolving demands of the healthcare sector. Franchisee partner receive comprehensive support, such as product upgrades, marketing assistance, and promotional materials. Come along with us as we significantly improve healthcare. Investigate our franchise opportunities to join us in promoting health and wellbeing.

Luckys Pharma Lab Pvt. Ltd is a premium pharmaceutical company based in Indore (MP). Being  a renowned supplier of high-quality healthcare, offering PCD pharma franchise possibilities in a number of therapeutic areas, including gynecology, respiratory, cardiac, and general. Our extensive product line satisfies the ever evolving demands of the healthcare sector. Franchisee partner receive comprehensive support, such as product upgrades, marketing assistance, and promotional materials. Come along with us as we significantly improve healthcare. Investigate our franchise opportunities to join us in promoting health and wellbeing.

Information about Razin DSR Capsule (Rabeprazole 20mg and Domperidone 30mg capsule) 

Razin DSR combines the benefits of Rabeprazole 20mg and Domperidone 30mg (SR) to provide effective relief from various gastrointestinal issues. Rabeprazole, a proton pump inhibitor, significantly reduces stomach acid production, making it highly effective in treating conditions like gastroesophageal reflux disease (GERD), ulcers, and Zollinger-Ellison syndrome. Domperidone, a dopamine antagonist, enhances gastric emptying and intestinal movement, thereby alleviating nausea, vomiting, and other symptoms of gastric discomfort. Together, they offer a comprehensive solution for maintaining digestive health and comfort.

Information about Razin DSR Capsule (Rabeprazole 20mg and Domperidone 30mg capsule) 

Razin DSR combines the benefits of Rabeprazole 20mg and Domperidone 30mg (SR) to provide effective relief from various gastrointestinal issues. Rabeprazole, a proton pump inhibitor, significantly reduces stomach acid production, making it highly effective in treating conditions like gastroesophageal reflux disease (GERD), ulcers, and Zollinger-Ellison syndrome. Domperidone, a dopamine antagonist, enhances gastric emptying and intestinal movement, thereby alleviating nausea, vomiting, and other symptoms of gastric discomfort. Together, they offer a comprehensive solution for maintaining digestive health and comfort.

Description

Salflo Nasal Spray is a saline nasal spray used to moisturize and relieve dry or irritated nasal passages. It contains a solution of sodium chloride (salt) in purified water and is free from any medications or additives. Saline nasal sprays are commonly used to alleviate symptoms associated with dry air, allergies, sinusitis, and nasal congestion.

Mechanism of Action

Saline nasal spray works by:

• Moisturizing the nasal mucosa: The saline solution helps hydrate and lubricate the nasal passages, reducing dryness and irritation.
• Clearing mucus: The spray can help loosen and thin mucus, making it easier to expel from the nasal passages.
• Promoting nasal hygiene: Saline solution helps cleanse the nasal passages by washing away debris, allergens, and irritants.

Indications

Salflo Nasal Spray is indicated for:

• Relief of dry nasal passages
• Alleviation of nasal congestion
• Relief of symptoms associated with allergies and sinusitis
• Maintenance of nasal hygiene

Salflo Res presents a pioneering solution for respiratory distress with its Salbutamol 2.5 mg Respule formulation. Designed to provide rapid relief for conditions such as asthma and chronic obstructive pulmonary disease (COPD), each respule contains a precise dose of Salbutamol, a fast-acting bronchodilator. Salbutamol works by relaxing the muscles in the airways, thereby opening them up and allowing for easier breathing. Salflo Res is meticulously crafted to deliver optimal efficacy and quick onset of action, ensuring prompt alleviation of respiratory symptoms.Manufactured under stringent quality control measures and in compliance with Good Manufacturing Practices (GMP), Salflo Res respules guarantee purity, safety, and consistency. Packaged for convenience and ease of use, each respule is accompanied by clear administration instructions, facilitating accurate dosing for patients of all ages. Additionally, comprehensive patient information leaflets provide essential guidance on the respule's uses, potential side effects, precautions, and contraindications. With a steadfast commitment to enhancing respiratory health and regulatory compliance, Salflo Res emerges as a trusted ally in the management of respiratory conditions, offering reliable relief and support for improved quality of life.

Budeflo G is an innovative rotacap formulation that combines glycopyrronium, formoterol fumarate, and budesonide, tailored for the management of chronic obstructive pulmonary disease (COPD) and other respiratory conditions. Each of these active ingredients plays a crucial role in providing comprehensive respiratory support.

Glycopyrronium is a long-acting muscarinic antagonist (LAMA) that works by blocking muscarinic receptors in the airways. This action helps to relax the muscles around the airways, reducing bronchoconstriction and improving airflow. By preventing acetylcholine from binding to these receptors, glycopyrronium promotes sustained bronchodilation, which is essential for managing COPD symptoms such as shortness of breath and wheezing.

Formoterol Fumarate, a long-acting beta-agonist (LABA), complements glycopyrronium's action by further relaxing the airway smooth muscles. It works by stimulating beta-2 adrenergic receptors, which enhances bronchodilation and helps to open up the airways. Formoterol fumarate provides rapid onset of action and sustained relief, making it effective in managing symptoms of COPD.

Budesonide is a potent corticosteroid that acts locally in the lungs to reduce inflammation. By inhibiting the production and release of inflammatory mediators, budesonide helps to decrease swelling and mucus production in the airways. This anti-inflammatory effect not only provides long-term control of COPD symptoms but also helps to prevent exacerbations.

Budeflo G is administered using a rotacap device, ensuring efficient delivery of the medication directly into the lungs. This method allows for optimal absorption of all three active ingredients, maximizing therapeutic benefits and minimizing systemic side effects.

Budeflo Forte is a combination rotacap containing glycopyrronium and formoterol fumarate, specifically formulated for the effective management of chronic obstructive pulmonary disease (COPD). Glycopyrronium is a long-acting muscarinic antagonist (LAMA) that works by inhibiting muscarinic receptors in the airway smooth muscle, leading to bronchodilation and reduced airway resistance. Formoterol fumarate is a long-acting beta-agonist (LABA) that relaxes the muscles around the airways, providing prolonged bronchodilation and facilitating easier breathing.

The combination of glycopyrronium and formoterol fumarate in Budeflo Forte offers a synergistic effect, ensuring both rapid and sustained relief from COPD symptoms such as shortness of breath, wheezing, and chronic cough. Glycopyrronium helps to keep the airways open by preventing bronchoconstriction, while formoterol provides continuous bronchodilation, improving lung function and enhancing overall respiratory capacity.

Budeflo Forte rotacaps are used with a Rotahaler device, which delivers the medication in a fine powder form directly to the lungs. This method ensures efficient drug delivery and optimal therapeutic effects. Typically, Budeflo Forte is administered twice daily, providing round-the-clock management of COPD symptoms.

Product Introduction: Telford H Tablet

Telford H Tablet is a combination medication formulated with two active ingredients aimed at effectively controlling high blood pressure. Typically prescribed when monotherapy is insufficient in managing blood pressure levels, Telford H Tablet plays a crucial role in reducing the risk of future heart attacks or strokes.

Usage Instructions:

• Telford H Tablet can be taken with or without food, offering flexibility in administration.
• The prescribed dosage of Telford H Tablet will be determined by your healthcare provider based on individual response to the medication and underlying medical condition. Consistency in daily intake, preferably at the same time each day, is advisable.
• It is imperative to continue taking Telford H Tablet until instructed otherwise by your doctor. Abrupt discontinuation may result in adverse cardiovascular events.
• Due to the diuretic component present in Telford H Tablet, increased urination may occur. To minimize disruption to sleep patterns, it is recommended to avoid ingestion within four hours of bedtime.
• Regular and consistent usage of Telford H Tablet, even in the absence of symptoms, is essential to maximize therapeutic benefits. Ceasing the medication without medical supervision may elevate the risk of heart-related complications.

BUDECIDE 0.5 Nebulizer Solution contains Budesonide 0.5 mg, a highly effective inhaled corticosteroid formulated to manage and prevent symptoms of asthma and chronic obstructive pulmonary disease (COPD). This solution works by directly targeting the airways to reduce inflammation, swelling, and mucus production, ensuring easier breathing and better control over respiratory conditions.

TROPIUM contains Ipratropium Bromide 500 mcg, a highly effective anticholinergic bronchodilator designed for the management of chronic obstructive pulmonary disease (COPD), bronchitis, and asthma. It works by inhibiting the muscarinic receptors in the airways, leading to relaxation of bronchial muscles and a reduction in mucus secretion. 

BUDEFLO 400 contains a combination of Budesonide (400mcg) and Formoterol (6 mcg), which is widely used for the effective management of respiratory conditions such as asthma and chronic obstructive pulmonary disease (COPD).

BUDEFLO 400 contains a combination of Budesonide (400mcg) and Formoterol (6 mcg), which is widely used for the effective management of respiratory conditions such as asthma and chronic obstructive pulmonary disease (COPD).

BUDEFLO 200 contains a combination of Budesonide (0.5 mg) and Formoterol (20 mcg), which is widely used for the effective management of respiratory conditions such as asthma and chronic obstructive pulmonary disease (COPD).

BUDEFLO 200 contains a combination of Budesonide (0.5 mg) and Formoterol (20 mcg), which is widely used for the effective management of respiratory conditions such as asthma and chronic obstructive pulmonary disease (COPD). 

BUDECIDE 1 mg Nebulizer Solution contains Budesonide 1 mg, a powerful inhaled corticosteroid formulated to manage and prevent symptoms of respiratory conditions such as asthma and chronic obstructive pulmonary disease (COPD).

BUDECIDE 0.5 Nebulizer Solution contains Budesonide 0.5 mg, a highly effective inhaled corticosteroid formulated to manage and prevent symptoms of asthma and chronic obstructive pulmonary disease (COPD). This solution works by directly targeting the airways to reduce inflammation, swelling, and mucus production, ensuring easier breathing and better control over respiratory conditions.

BUDEFLO-G FORTE: Triple Therapy for Enhanced Respiratory Care

BUDEFLO-G FORTE, delivered through an advanced Keyhaler device, combines Glycopyrrolate 25 mcg, Formoterol 12 mcg, and Budesonide 400 mcg to provide superior management of severe asthma and chronic obstructive pulmonary disease (COPD). Glycopyrrolate acts as a long-acting muscarinic antagonist (LAMA), reducing airway constriction and improving airflow. Formoterol, a long-acting beta-agonist (LABA), ensures rapid and sustained bronchodilation, offering quick relief from breathing difficulties. Budesonide, a powerful inhaled corticosteroid (ICS), reduces airway inflammation and prevents exacerbations. 

Lucky Pharma Lab Pvt Ltd is excited to extend franchise opportunities in Respules across India. Respules, also known as inhalation solutions, are essential for managing respiratory conditions such as asthma, chronic obstructive pulmonary disease (COPD), and bronchitis. As a trusted pharmaceutical company dedicated to enhancing respiratory health, we offer franchise partnerships to empower entrepreneurs and healthcare professionals in delivering high-quality Respules to patients nationwide.

By joining hands with Lucky Pharma Lab Pvt Ltd, franchisees gain access to a comprehensive range of Respules renowned for their efficacy, safety, and reliability. Our commitment to quality assurance ensures that patients receive top-notch respiratory medications, contributing to better health outcomes and improved quality of life.

Budven 0.5 is a nebulizer suspension containing budesonide, a potent corticosteroid, formulated for the treatment and management of asthma and chronic obstructive pulmonary disease (COPD). Budesonide works by reducing inflammation in the airways, leading to decreased swelling and mucus production, which helps prevent asthma attacks and control COPD symptoms. This medication is particularly effective in providing long-term relief from respiratory conditions by targeting the underlying inflammation that contributes to breathing difficulties.

Leval 0.31 is a respiratory solution containing levosalbutamol, a selective beta-2 adrenergic agonist used for the treatment of bronchospasm associated with conditions such as asthma and chronic obstructive pulmonary disease (COPD). Levosalbutamol is the active enantiomer of salbutamol, which means it specifically targets beta-2 receptors in the lungs, leading to smooth muscle relaxation and subsequent bronchodilation. This action helps to quickly open the airways, making breathing easier and providing relief from symptoms such as wheezing, shortness of breath, and chest tightness.

Administered via a nebulizer, Leval 0.31 is particularly effective for patients who may have difficulty using traditional inhalers, including young children, elderly individuals, or those experiencing severe respiratory distress. The nebulizer converts the solution into a fine mist, ensuring that the medication reaches deep into the lungs for optimal absorption and rapid onset of action.

Leval 0.31 is typically used as needed to relieve acute bronchospasm or as part of a maintenance regimen to prevent symptoms triggered by exercise or environmental factors. Its rapid action and effectiveness in opening airways make it an essential medication for managing acute episodes of respiratory distress.

Leval 1.25 is a pharmaceutical brand specializing in respiratory care, offering respules containing 1.25 mg of Levosalbutamol. Levosalbutamol, also known as levalbuterol, is a selective beta2-adrenergic receptor agonist bronchodilator used to alleviate symptoms associated with respiratory conditions such as asthma and chronic obstructive pulmonary disease (COPD). By stimulating beta2 receptors in the lungs, Levosalbutamol relaxes the smooth muscles of the airways, facilitating easier breathing and relieving bronchospasm. Leval 1.25 respules provide a convenient and precise dosage form for patients, ensuring optimal delivery of the medication directly to the lungs. This formulation offers rapid relief from bronchoconstriction and improves airflow, thereby enhancing respiratory function and promoting better symptom control. Leval 1.25 is a trusted choice for individuals seeking effective management of their respiratory symptoms, allowing them to breathe more comfortably and lead active lifestyles.

Gyflo is an inhalation solution containing glycopyrronium bromide, a long-acting muscarinic antagonist (LAMA) designed to manage chronic obstructive pulmonary disease (COPD). Glycopyrronium works by blocking muscarinic receptors in the bronchial smooth muscle, preventing the action of acetylcholine, a neurotransmitter that causes bronchoconstriction. This leads to relaxation of the airway muscles, resulting in prolonged bronchodilation and improved airflow, making it easier for patients to breathe.

Gyflo, with a dosage of 25 mcg per inhalation, is administered via a nebulizer, which converts the solution into a fine mist for direct delivery to the lungs. This method ensures that the medication is effectively absorbed in the respiratory tract, providing targeted relief from symptoms such as chronic cough, wheezing, and shortness of breath. The long-acting nature of glycopyrronium means that Gyflo provides sustained bronchodilation, reducing the frequency of COPD exacerbations and improving overall lung function.

Roset Gold 10/20 is a combination capsule that includes rosuvastatin, aspirin, and clopidogrel, offering a comprehensive approach to cardiovascular disease management. Rosuvastatin, a potent statin, effectively lowers low-density lipoprotein (LDL) cholesterol and triglycerides while increasing high-density lipoprotein (HDL) cholesterol, thus reducing the risk of atherosclerosis and coronary artery disease by inhibiting HMG-CoA reductase. Aspirin, an antiplatelet agent, inhibits the cyclooxygenase-1 (COX-1) enzyme, preventing the formation of thromboxane A2 and reducing platelet aggregation, thereby lowering the risk of thrombus formation. Clopidogrel, another antiplatelet drug, inhibits the P2Y12 component of ADP receptors on platelets, enhancing the prevention of platelet aggregation. This combination is particularly beneficial for patients who have a history of myocardial infarction, unstable angina, or have undergone procedures like stent placement or other revascularization interventions. Roset Gold 10/20 is tailored for secondary prevention in high-risk patients, aiming to reduce the incidence of heart attacks, strokes, and other cardiovascular events. For optimal results, patients should adhere to their prescribed regimen and maintain lifestyle changes such as a heart-healthy diet, regular physical activity, and smoking cessation. Regular monitoring of lipid levels, renal function, and vigilance for signs of bleeding is essential to ensure the safety and effectiveness of this treatment.

Levoice M is a sophisticated combination tablet that contains Levocetirizine 5mg and Montelukast 10mg, designed to provide extensive relief from allergic symptoms and improve the quality of life for individuals dealing with allergies. Levocetirizine, a third-generation non-sedating antihistamine, works by blocking the histamine receptors in the body, thereby reducing the effects of histamine, a substance that the body releases during an allergic reaction. This leads to a significant decrease in symptoms such as itching, runny nose, sneezing, and watery eyes. On the other hand, Montelukast is a leukotriene receptor antagonist that functions by inhibiting the leukotrienes, which are inflammatory chemicals the body releases in response to allergens. By preventing the action of leukotrienes, Montelukast helps reduce airway inflammation, bronchoconstriction, and nasal congestion, making it highly effective in treating both allergic rhinitis and asthma. The dual-action of Levoice M ensures a comprehensive approach to allergy management, targeting different pathways of the allergic response for more effective symptom control. This combination therapy is especially beneficial for individuals who experience persistent and troublesome allergic symptoms that interfere with daily activities. Levoice M, taken once daily, offers the convenience of a simplified treatment regimen, encouraging better compliance and consistent relief from allergy symptoms. With Levoice M, patients can experience fewer interruptions in their daily lives, maintaining their health and well-being with a dependable and effective allergy treatment.

Levoice M is a sophisticated combination tablet that contains Levocetirizine 5mg and Montelukast 10mg, designed to provide extensive relief from allergic symptoms and improve the quality of life for individuals dealing with allergies. Levocetirizine, a third-generation non-sedating antihistamine, works by blocking the histamine receptors in the body, thereby reducing the effects of histamine, a substance that the body releases during an allergic reaction. This leads to a significant decrease in symptoms such as itching, runny nose, sneezing, and watery eyes. On the other hand, Montelukast is a leukotriene receptor antagonist that functions by inhibiting the leukotrienes, which are inflammatory chemicals the body releases in response to allergens. By preventing the action of leukotrienes, Montelukast helps reduce airway inflammation, bronchoconstriction, and nasal congestion, making it highly effective in treating both allergic rhinitis and asthma. The dual-action of Levoice M ensures a comprehensive approach to allergy management, targeting different pathways of the allergic response for more effective symptom control. This combination therapy is especially beneficial for individuals who experience persistent and troublesome allergic symptoms that interfere with daily activities. Levoice M, taken once daily, offers the convenience of a simplified treatment regimen, encouraging better compliance and consistent relief from allergy symptoms. With Levoice M, patients can experience fewer interruptions in their daily lives, maintaining their health and well-being with a dependable and effective allergy treatment.

Levoice M is a sophisticated combination tablet that contains Levocetirizine 5mg and Montelukast 10mg, designed to provide extensive relief from allergic symptoms and improve the quality of life for individuals dealing with allergies. Levocetirizine, a third-generation non-sedating antihistamine, works by blocking the histamine receptors in the body, thereby reducing the effects of histamine, a substance that the body releases during an allergic reaction. This leads to a significant decrease in symptoms such as itching, runny nose, sneezing, and watery eyes. On the other hand, Montelukast is a leukotriene receptor antagonist that functions by inhibiting the leukotrienes, which are inflammatory chemicals the body releases in response to allergens. By preventing the action of leukotrienes, Montelukast helps reduce airway inflammation, bronchoconstriction, and nasal congestion, making it highly effective in treating both allergic rhinitis and asthma. The dual-action of Levoice M ensures a comprehensive approach to allergy management, targeting different pathways of the allergic response for more effective symptom control. This combination therapy is especially beneficial for individuals who experience persistent and troublesome allergic symptoms that interfere with daily activities. Levoice M, taken once daily, offers the convenience of a simplified treatment regimen, encouraging better compliance and consistent relief from allergy symptoms. With Levoice M, patients can experience fewer interruptions in their daily lives, maintaining their health and well-being with a dependable and effective allergy treatment.

Efurt 250 introduces a cutting-edge solution for bacterial infections with its Cefuroxime Tablet formulation. Each tablet contains a potent dose of Cefuroxime, a second-generation cephalosporin antibiotic renowned for its broad-spectrum activity against a variety of pathogens. Cefuroxime works by inhibiting bacterial cell wall synthesis, effectively eradicating bacteria responsible for infections ranging from respiratory tract infections to urinary tract infections and skin infections. Efurt's Cefuroxime Tablets are meticulously crafted to deliver targeted therapy and promote rapid recovery.

Budecide 0.5 introduces a breakthrough solution for respiratory conditions with its Budesonide Respules. Each respule contains a precise dose of Budesonide, a corticosteroid renowned for its effectiveness in managing asthma, chronic obstructive pulmonary disease (COPD), and other respiratory ailments. Budesonide works by reducing inflammation in the airways, thereby alleviating symptoms such as wheezing, coughing, and shortness of breath. Budecide 0.5 is meticulously formulated to provide targeted relief and promote respiratory wellness. Manufactured under stringent quality control measures and in compliance with Good Manufacturing Practices (GMP), Budecide ensures the purity, safety, and consistency of each respule. Packaged for convenience and ease of use, each respule comes with clear instructions for administration, ensuring precise dosing for patients of all ages. Additionally, comprehensive patient information leaflets provide essential guidance on the respule's uses, potential side effects, precautions, and contraindications. With a steadfast commitment to respiratory health and regulatory compliance, Budecide 0.5 emerges as a trusted ally in the management of respiratory conditions, offering reliable relief and support for improved quality of life.

Lucky Pharma Lab Pvt Ltd is excited to extend franchise opportunities in Respules across India. Respules, also known as inhalation solutions, are essential for managing respiratory conditions such as asthma, chronic obstructive pulmonary disease (COPD), and bronchitis. As a trusted pharmaceutical company dedicated to enhancing respiratory health, we offer franchise partnerships to empower entrepreneurs and healthcare professionals in delivering high-quality Respules to patients nationwide.

By joining hands with Lucky Pharma Lab Pvt Ltd, franchisees gain access to a comprehensive range of Respules renowned for their efficacy, safety, and reliability. Our commitment to quality assurance ensures that patients receive top-notch respiratory medications, contributing to better health outcomes and improved quality of life.

Leval 1.25 respule containing levosalbutamol in a 1.25mg strength provided in the form of respules. Levosalbutamol is a bronchodilator medication that belongs to the class of beta 2 adrenergic agonists. It is primarily used to relieve symptoms of bronchoconstrictions such as wheezing shortness of breath and chest tightness commonly associated with conditions like asthma, chronic obstructive pulmonary disease and bronchitis. Leval 1.25 works by relaxing the smooth muscles in the airways, thereby faciliating easier breathing and improving airflow to the lungs.&nbsp;<br /><br />

Telford - AM Tablet Overview:

Telford - AM Tablet is a combination medication designed to manage high blood pressure (hypertension). It contains two active ingredients that work synergistically to lower blood pressure by relaxing blood vessels, thus easing the heart's workload and reducing the risk of heart attack or stroke.

Administration:

• Telford - AM Tablet can be taken on an empty stomach or with food, but it is recommended to take it consistently at the same time each day as prescribed by your doctor.
• Dosage will vary depending on your individual condition and response to the medication. It's important to adhere to the prescribed regimen.
• Even if you feel well, continue taking the medication as directed. Consistent use is crucial for effectively reducing the risk of heart attack or stroke.

Treatment of Hypertension:

• Telford - AM Tablet effectively treats hypertension, a condition characterized by elevated blood pressure levels.
• The combination of active ingredients in this medication works through different mechanisms to lower blood pressure. By relaxing blood vessels and facilitating smoother blood flow, it reduces the strain on the heart and decreases the risk of cardiovascular complications such as heart attack, stroke, or kidney problems.
• While you may not feel an immediate effect from taking this medication, its long-term benefits lie in maintaining stable blood pressure levels and preserving overall health.

Luckys Pharma Lab Pvt. Ltd is a premium pharmaceutical company based in Indore (MP). Being  a renowned supplier of high-quality healthcare, offering PCD pharma franchise possibilities in a number of therapeutic areas, including gynecology, respiratory, cardiac, and general. Our extensive product line satisfies the ever evolving demands of the healthcare sector. Franchisee partner receive comprehensive support, such as product upgrades, marketing assistance, and promotional materials. Come along with us as we significantly improve healthcare. Investigate our franchise opportunities to join us in promoting health and wellbeing.